TY - JOUR
T1 - Supraventricular tachycardias, conduction disease, and cardiomyopathy in 3 families with the same rare variant in TNNI3K (p.Glu768Lys)
AU - Podliesna, Svitlana
AU - Delanne, Julian
AU - Miller, Lindsey
AU - Tester, David J.
AU - Uzunyan, Merujan
AU - Yano, Shoji
AU - Klerk, Mischa
AU - Cannon, Bryan C.
AU - Khongphatthanayothin, Apichai
AU - Laurent, Gabriel
AU - Bertaux, Geraldine
AU - Falcon-Eicher, Sylvie
AU - Wu, Shengnan
AU - Yen, Hai-Yun
AU - Gao, Hanlin
AU - Wilde, Arthur A. M.
AU - Faivre, Laurence
AU - Ackerman, Michael J.
AU - Lodder, Elisabeth M.
AU - Bezzina, Connie R.
PY - 2019
Y1 - 2019
N2 - Background: Rare genetic variants in TNNI3K encoding troponin-I interacting kinase have been linked to a distinct syndrome consisting primarily of supraventricular tachycardias and variably expressed conduction disturbance and dilated cardiomyopathy in 2 families. Objective: The purpose of this study was to identify new genetic variants associated with inherited supraventricular tachycardias, cardiac conduction disease, and cardiomyopathy. Methods: We conducted next generation sequencing in 3 independent multigenerational families with atrial/junctional tachycardia with or without conduction disturbance, dilated cardiomyopathy, and sudden death. We also assessed the effect of identified variant on protein autophosphorylation. Results: In this study, we uncovered the same ultra-rare genetic variant in TNNI3K (c.2302G>A, p.Glu768Lys), which co-segregated with disease features in all affected individuals (n = 23) from all 3 families. TNNI3K harboring the TNNI3K-p.Glu768Lys variant displayed enhanced kinase activity, in line with expectations from previous mouse studies that demonstrated increased conduction indices and procardiomyopathic effects with increased levels of Tnni3k. Conclusion: This study corroborates further the causal link between rare genetic variation in TNNI3K and this distinct complex phenotype, and points to enhanced kinase activity of TNNI3K as the underlying pathobiological mechanism.
AB - Background: Rare genetic variants in TNNI3K encoding troponin-I interacting kinase have been linked to a distinct syndrome consisting primarily of supraventricular tachycardias and variably expressed conduction disturbance and dilated cardiomyopathy in 2 families. Objective: The purpose of this study was to identify new genetic variants associated with inherited supraventricular tachycardias, cardiac conduction disease, and cardiomyopathy. Methods: We conducted next generation sequencing in 3 independent multigenerational families with atrial/junctional tachycardia with or without conduction disturbance, dilated cardiomyopathy, and sudden death. We also assessed the effect of identified variant on protein autophosphorylation. Results: In this study, we uncovered the same ultra-rare genetic variant in TNNI3K (c.2302G>A, p.Glu768Lys), which co-segregated with disease features in all affected individuals (n = 23) from all 3 families. TNNI3K harboring the TNNI3K-p.Glu768Lys variant displayed enhanced kinase activity, in line with expectations from previous mouse studies that demonstrated increased conduction indices and procardiomyopathic effects with increased levels of Tnni3k. Conclusion: This study corroborates further the causal link between rare genetic variation in TNNI3K and this distinct complex phenotype, and points to enhanced kinase activity of TNNI3K as the underlying pathobiological mechanism.
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85052744493&origin=inward
UR - https://www.ncbi.nlm.nih.gov/pubmed/30010057
U2 - https://doi.org/10.1016/j.hrthm.2018.07.015
DO - https://doi.org/10.1016/j.hrthm.2018.07.015
M3 - Article
C2 - 30010057
SN - 1547-5271
VL - 16
SP - 98
EP - 105
JO - Heart Rhythm
JF - Heart Rhythm
IS - 1
ER -